KG
PFE icon

Kilter Group’s Pfizer PFE Stock Holding History

Kilter Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.1K Sell
1,166
-79
-6% -$2.07K 0.01% 213
2026
Q1 		$35K Buy
1,245
+192
+18% +$5.11K 0.02% 157
2025
Q4 		$26.2K Buy
1,053
+325
+45% +$8.2K 0.01% 176
2025
Q3 		$18.5K Buy
728
+48
+7% +$1.19K 0.01% 201
2025
Q2 		$16.5K Buy
+680
New +$15.9K 0.01% 197

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kilter Group's PFE Position: Q2 2026 in Review

Kilter Group reduced its Pfizer (PFE) stake by 6.3% in Q2 2026, selling an estimated $2.07K and leaving 1,166 shares worth $28.1K. The position accounts for 0.01% of the portfolio, ranked #213.

Kilter Group first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $35K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kilter Group held 1,166 shares of Pfizer worth $28.1K as of Q2 2026.
  • Kilter Group sold 79 Pfizer shares in Q2 2026, an estimated $2.07K.
  • Pfizer made up 0.01% of Kilter Group's portfolio in Q2 2026, its #213 holding.
  • Kilter Group first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Pfizer position peaked at $35K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.